-
A7 to unveil a service that will re-invent the international payments market
-
Brazilian judge allows Flavio Bolsonaro to visit jailed father
-
'Status quo' with EU 'not good enough', UK PM says as summit date set
-
France braces for fresh student demonstrations as Macron calls for 'respect'
-
Stolen Renoir paintings found behind wall in France
-
Zelensky doubtful on Russian acceptance of Trump's 'energy ceasefire'
-
French supermarkets suffer refrigerator shutdown after 'unprecedented' cyberattack
-
Federal agents search home of Trump critic Ilhan Omar: government
-
Arsenal lose Hincapie and Zubimendi in freak double blow
-
Pakistan detains hundreds from ex-PM Khan's party as protests falter
-
Saudi says resilience tested, vows response after deadly airport attacks
-
Australia's Smith off field after being struck on helmet
-
Alcaraz exits Shanghai Masters in straight-sets loss
-
UK retains early access to test latest US AI models
-
Pope to enter hospital on Tuesday for lung operation
-
Top NATO commander warns Russia any attack would be 'futile'
-
Renshaw shines again before Australia declaration
-
Stolen Renoir paintings found behind wall in France: prosecutor
-
Atletico's Simeone encourages goalless Alvarez improvement
-
UNHCR sounds alarm on funding crisis
-
FXGLOBE Rebuilds Its Copy Trading and PAMM Business With B2BROKER's B2COPY
-
French supermarket chains say cyberattack forced refrigerator shutdown
-
Nepal rescuers search for missing after flash flood
-
Minister's resignation rocks German coalition
-
Oil rises as Trump comments roil energy markets
-
Hurricane Simon lashes Mexico's Pacific coast, threatens landfall
-
Premier League in limbo as Manchester City soar
-
France schools protest rumbles on as Macron urges 'respect'
-
Zelensky vows to respond as Moscow silent on 'energy ceasefire'
-
Americans Hall and Woodford win economics Nobel for stabilisation models
-
Thousands march in India's capital to demand election chief resign
-
MEXC Brings AI, TradFi and the Future of Trading to Life at TOKEN2049 Singapore
-
African players in Europe: Mbeumo ends goal drought as United draw
-
Italian rice farmer beats heat with biodiversity haven
-
France's high school students plan fresh protests
-
Stocks mixed as oil prices slip after Trump hails 'energy ceasefire'
-
NZ bank in free speech row over 'explicit' sheep memes
-
Opposition, journalists allege police abuses during India protests
-
China Open champ Zheng withdraws from Wuhan citing fatigue
-
DATA Network joins Sui and Walrus to scale the supply chain for AI training data
-
Brewers edge Dodgers 2-1 in National League Championship Series opener
-
Melbourne man linked to suspected flydubai hijacker condemns 'false accusations'
-
Pope to have surgery to remove lung nodule
-
North Korea fires 'several ballistic missiles' into Sea of Japan
-
Stocks rise as oil prices tumble after Trump hails 'energy ceasefire'
-
El Nino sets temperature record in key Pacific zone: EU monitor
-
Man City charges cloud hangs over Premier League season
-
Nature does not respect borders: UN biodiversity chief
-
Top NATO commander set to issue warning to Russia over any attack
-
World leaders urged to 'course correct' as UN nature goals fall short
US family reaches deal over cells harvested in 1950s
A US biotechnology company has reached a settlement with the family of Henrietta Lacks, an African-American woman whose cells were used for groundbreaking medical research without her consent.
Civil rights attorney Ben Crump, who filed a lawsuit in 2021 on behalf of the Lacks' estate, announced on Tuesday that the family had agreed a confidential deal with Massachusetts-based firm Thermo Fisher Scientific.
"The parties are pleased that they were able to find a way to resolve this matter outside of court," Crump said, noting that Tuesday would have been Lacks' 103rd birthday.
Crump, who has represented the family of George Floyd and other Black victims of US police violence, said the settlement provides "some measure of justice for Henrietta Lacks, 70 years later."
The 31-year-old Lacks, a tobacco farmer from Virginia and mother of five, died of cervical cancer in 1951 at Johns Hopkins Hospital in Baltimore.
During attempts to cure her shortly before she died, Lacks' abnormally resilient cancer cells were removed from her tumor and were used for decades by researchers without her family's knowledge.
The cells, dubbed HeLa for the first letters of her first and last names, were the first-ever human cells to grow endlessly in the lab -- all others harvested up to that point died.
- Nobel Prizes -
Research using the cells led to Nobel Prize-winning discoveries, and laboratories worldwide used them to develop vaccines -- notably against polio -- as well as in cloning, in-vitro fertilization and many medicines, fueling an industry now worth billions of dollars.
The family knew nothing of Lacks' role until the 1970s, and only came to understand its full scope thanks to the work of Rebecca Skloot, author of the 2010 bestseller "The Immortal Life of Henrietta Lacks."
Lacks' story was also the subject of an HBO movie starring Oprah Winfrey.
"They treated her like a specimen, like a lab rat," her grand-daughter Kimberly Lacks said in 2021, describing the cell theft as racism.
Thermo Fisher Scientific confirmed the settlement, using the same language as the family lawyers Crump and Chris Seeger.
In filing the lawsuit in 2021, Seeger said that Thermo Fisher was the first of many companies that could face legal action for having "profited from the use" of the HeLa cells.
On its website, Johns Hopkins Hospital said that it has never sold or benefited from the discovery or distribution of HeLa cells, and does not own the rights to them.
"HeLa cells were offered freely and widely by Johns Hopkins for scientific research," it said.
"Johns Hopkins has worked in close coordination with several members of the Lacks family over the past decade to recognize and honor Henrietta Lacks, including scholarships, engagement with local schools and annual symposia," it added.
Y.Bouchard--BTB